B. Maciejewski

Is acute mucositis a dose limiting factor in altered fractionated radiotherapy

B. Maciejewski, 1997 .

Dose-response curve and split-dose recovery in human skin cancer.

K. Trott, J. Skołyszewski, B. Maciejewski, 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

The influence of the number of fractions, overall treatment time and field size on the local control of cancer of the skin.

K. Trott, B. Maciejewski, A. Hliniak, 1983, The British journal of radiology.

The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx.

K. Trott, B. Maciejewski, G. Preuss-Bayer, 1981, International journal of radiation oncology, biology, physics.

Regression rate of metastatic neck lymph nodes after radiation treatment as a prognostic factor for local control.

B. Maciejewski, 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation.

J. M. Taylor, H. Withers, B. Maciejewski, 1989, International journal of radiation oncology, biology, physics.

The hazard of accelerated tumor clonogen repopulation during radiotherapy.

J. M. Taylor, H. Withers, J. M. Taylor, 1988, Acta oncologica.

Planned and unplanned gaps in radiotherapy: the importance of gap position and gap duration.

B. Maciejewski, G. Steel, K. Składowski, 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Fever-range whole body hyperthermia leads to changes in immune-related genes and miRNA machinery in Wistar rats.

T. Jędrzejewski, S. Wrotek, A. Dzialuk, 2023, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events

Oliver C. Turner, V. Sasseville, M. Scharenberg, 2023, Science Translational Medicine.

Concept of biologically normalized dose-volume histograms for 3D radiation treatment planning

A. Niemierko, A. Zajusz, B. Maciejewski, 1996 .